Liisa I. Nogelo - 21 Jul 2021 Form 4 Insider Report for Surface Oncology, Inc.

Reporting relationship: Chief Legal Officer
Issuer ticker: N/A
Reported as of: 21 Jul 2021
Net transaction value: -$160,582
SEC form: 4
Accepted by SEC: 14 Jan 2022, 19:30:22 UTC
Source filing: View source filing
Reporting owner signature: /s/ Jessica Fees, as Attorney-in-Fact

Key filing fact

Liisa I. Nogelo filed Form 4 for Surface Oncology, Inc. on 14 Jan 2022.

Key facts

This page summarizes Liisa I. Nogelo's Form 4 filing for Surface Oncology, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Jan 2022, 19:30.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: -$160,582.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SURF transaction

Common Stock

Sale

Transaction value: $160,582
Shares: -26,325
Change %: -33%
Price: $6.10^*
Shares after: 53,675
Date: 21 Jul 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Amount reported represents the number of shares sold by the reporting person to cover the tax withholding obligations in connection with the vesting of restricted stock units.